HK77989A - Compositions comprising interferon and their therapeutic use - Google Patents

Compositions comprising interferon and their therapeutic use

Info

Publication number
HK77989A
HK77989A HK779/89A HK77989A HK77989A HK 77989 A HK77989 A HK 77989A HK 779/89 A HK779/89 A HK 779/89A HK 77989 A HK77989 A HK 77989A HK 77989 A HK77989 A HK 77989A
Authority
HK
Hong Kong
Prior art keywords
interferon
compositions
therapeutic use
hyroxymethyl
guanine
Prior art date
Application number
HK779/89A
Other languages
English (en)
Inventor
Kendall O Smith
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of HK77989A publication Critical patent/HK77989A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK779/89A 1982-11-04 1989-09-28 Compositions comprising interferon and their therapeutic use HK77989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/439,121 US4462986A (en) 1982-11-04 1982-11-04 Synergistic anti-herpes compositions

Publications (1)

Publication Number Publication Date
HK77989A true HK77989A (en) 1989-10-06

Family

ID=23743382

Family Applications (1)

Application Number Title Priority Date Filing Date
HK779/89A HK77989A (en) 1982-11-04 1989-09-28 Compositions comprising interferon and their therapeutic use

Country Status (10)

Country Link
US (1) US4462986A (de)
EP (1) EP0109234B1 (de)
JP (1) JPS59130223A (de)
AT (1) ATE26216T1 (de)
AU (1) AU557894B2 (de)
CA (1) CA1239093A (de)
DE (1) DE3370587D1 (de)
HK (1) HK77989A (de)
MC (1) MC1552A1 (de)
ZA (1) ZA838179B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4857316A (en) * 1984-10-03 1989-08-15 Syntex (U.S.A.) Inc. Synergistic antiviral composition
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
JP2525104B2 (ja) * 1992-03-24 1996-08-14 日本碍子株式会社 樹脂含浸紙コンデンサコアおよびその製造方法
US5550114A (en) * 1993-04-02 1996-08-27 Thomas Jefferson University Epidermal growth factor inhibitor
FI973784A (fi) * 1997-09-25 1999-03-26 Huhtamaeki Oy Ksylitolikaramelli, erityisesti kovakaramelli
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
WO2003030613A2 (en) * 2001-10-05 2003-04-17 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
EP1674104A1 (de) * 2004-12-24 2006-06-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Uridinderivaten als antivirale Agentien gegen Flavividae, insbesonders HCV
CA2644127A1 (fr) * 2006-03-08 2007-09-13 Biomethodes Variants ameliores de l'interferon-gamma humain (ifny)
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2134292A1 (en) * 1971-04-30 1972-12-08 Inst Nat Sante Rech Med Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
AU569462B2 (en) * 1981-08-11 1988-02-04 Wellcome Foundation Limited, The Antiviral purine derivatives
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
EP0080032A3 (de) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmazeutische Zubereitung für die Behandlung von herpetischen Verletzungen
MC1585A1 (fr) * 1982-02-12 1985-02-22 Ens Bio Logicals Inc Procede de fabrication de compositions antivirales

Also Published As

Publication number Publication date
AU2068183A (en) 1984-05-10
ATE26216T1 (de) 1987-04-15
EP0109234B1 (de) 1987-04-01
US4462986A (en) 1984-07-31
AU557894B2 (en) 1987-01-15
EP0109234A1 (de) 1984-05-23
DE3370587D1 (en) 1987-05-07
ZA838179B (en) 1985-03-27
CA1239093A (en) 1988-07-12
MC1552A1 (fr) 1984-08-31
JPS59130223A (ja) 1984-07-26

Similar Documents

Publication Publication Date Title
DE3370587D1 (en) Compositions comprising interferon and their therapeutic use
AU589371B2 (en) Purine derivatives and use as therapeutic agent
AU623512B2 (en) Phenyl pyrimidone derivatives, processes for their preparation, and their use therapeutic agents
ZA928832B (en) Local delivery of dipyridamole for the treatment of proliferative diseases
PL299015A1 (en) Desquamative composition for use on human skin
HK1002426A1 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
GB8914060D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
IL100195A0 (en) Use of xanthines for the preparation of a medicament having immuno suppressing activity
GR3030150T3 (en) Use of Human Interferon-Beta 2A for the preparation of medicaments
DE3277726D1 (en) Use of alkaloid derivatives for the manufacture of a medicament for the strengthening of the immune system and for the treatment of viral, bacterial and fungal infections
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
GB8914061D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
IL98849A0 (en) (2r)-2-(di-(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use
EP0212501A3 (en) Therapeutic agent for treating hematopoietic diseases
GB8914062D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
EP0280593A3 (en) Composition on the basis of an amino-acid and vitamins for use in cancer therapy
DE3176462D1 (en) Deazapurine nucleoside, formulations thereof, and use thereof in therapy
CY2339B1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections.
ZA893261B (en) Synergistic combinations and their use as therapeutic agents
ZW5790A1 (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
MY112888A (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases.
IL100179A0 (en) The use of carbazones as novel active ingredients in medicaments
AU102687S (en) Nomogram for medical use
ZA902254B (en) Use of purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use